Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Revenue

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹5,617 Cr₹5,665 Cr₹3,625 Cr₹4,401 Cr₹3,463 Cr

What is the latest Revenue of GLAND PHARMA ?

The latest Revenue ratio of GLAND PHARMA is ₹5,617 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹5,617 Cr
Mar2025₹5,665 Cr
Mar2024₹3,625 Cr
Mar2023₹4,401 Cr
Mar2022₹3,463 Cr

How is Revenue of GLAND PHARMA Trending?

Years Revenue % Change
Mar2026 ₹5,617 Cr
-0.85
Mar2025 ₹5,665 Cr
56.29
Mar2024 ₹3,625 Cr
-17.64
Mar2023 ₹4,401 Cr
27.08
Mar2022 ₹3,463 Cr -

Compare Revenue of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹48,104.1 Cr -0.9% 0.3% 43.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.9%

0.3%

43.3%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses